The efficacy and safety of the reducing dose HAA regimen as induction chemotherapy in previously untreated elderly patients aged 60-69 years with acute myeloid leukemia.
- Author:
Peipei YE
1
;
Feifei CHEN
1
;
Qitian MU
1
;
Wenyuan MAI
1
;
Haitao MENG
1
;
Wenbin QIAN
1
;
Hongyan TONG
1
;
Jian HUANG
1
;
Yin TONG
1
;
Zhimei CHEN
1
;
Jiyu LOU
1
;
Yungui WANG
1
;
Wanmao NI
1
;
Jie JIN
1
Author Information
- Publication Type:Journal Article
- MeSH: Aged; Antineoplastic Combined Chemotherapy Protocols; therapeutic use; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; drug therapy; Middle Aged
- From: Chinese Journal of Hematology 2014;35(9):845-847
- CountryChina
- Language:Chinese
